tiprankstipranks
Trending News
More News >
ASGN Incorporated (ASGN)
NYSE:ASGN
Advertisement

ASGN (ASGN) AI Stock Analysis

Compare
214 Followers

Top Page

ASGN

ASGN

(NYSE:ASGN)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
$50.00
▲(14.94% Upside)
ASGN's overall stock score reflects a mixed outlook. The company's financial performance shows challenges in revenue growth and profitability, which are significant concerns. However, the earnings call provided positive insights into growth in IT consulting and healthcare sectors. The technical analysis suggests a bearish trend, while the valuation appears reasonable. These factors combined result in a moderate overall score.
Positive Factors
IT Consulting Growth
The strong performance in IT consulting indicates a robust demand for ASGN's services, positioning the company well for sustained growth in this sector.
Federal Segment Strength
The strong bookings in the federal segment suggest a stable revenue stream and potential for future growth, enhancing ASGN's market position.
AI and Digital Transformation
The focus on AI and digital transformation projects positions ASGN to capitalize on industry trends, driving long-term growth and innovation.
Negative Factors
Revenue Decline
The decline in revenue indicates challenges in maintaining sales momentum, which could impact ASGN's ability to sustain growth.
Assignment Revenue Decrease
The significant drop in assignment revenues reflects vulnerabilities to economic cycles, potentially affecting ASGN's financial stability.
Free Cash Flow Decline
The decline in free cash flow growth raises concerns about ASGN's liquidity and its ability to fund operations and growth initiatives.

ASGN (ASGN) vs. SPDR S&P 500 ETF (SPY)

ASGN Business Overview & Revenue Model

Company DescriptionASGN Incorporated is a leading provider of technology and workforce solutions in the United States. Operating primarily in the IT and professional services sectors, ASGN offers a range of services including staffing, consulting, and managed services. The company serves diverse industries such as government, healthcare, and commercial sectors, leveraging its expertise to deliver innovative solutions that address complex business challenges.
How the Company Makes MoneyASGN generates revenue primarily through its staffing and consulting services, which include temporary placements, permanent placements, and project-based consulting. The company earns fees from clients based on the services rendered, often charging hourly rates for temporary staffing and a percentage of the hired employee's salary for permanent placements. Additionally, ASGN has established significant partnerships with various organizations, allowing it to expand its service offerings and client base. The company also benefits from long-term contracts with government agencies, providing a stable revenue stream. Overall, ASGN's diverse portfolio and strategic partnerships contribute significantly to its earnings.

ASGN Earnings Call Summary

Earnings Call Date:Oct 22, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 11, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture with solid performance in IT consulting and healthcare sectors, but challenges in revenue decline, assignment revenues, and the potential impact of the government shutdown. The highlights and lowlights reflect a balanced outlook with positive growth prospects tempered by existing challenges.
Q3-2025 Updates
Positive Updates
Solid Revenue and EBITDA Performance
ASGN delivered solid performance in the third quarter, with revenues reaching $1.01 billion and an adjusted EBITDA margin of 11.1%, both at the high end of guidance ranges.
Growth in IT Consulting
The IT consulting business continues to be a key growth driver, representing approximately 63% of total revenues in the third quarter, up from 58% in the same period last year.
Increase in AI and Data Projects
ASGN has seen an increase in projects focused on data and AI, application development and engineering, customer experience, and cybersecurity, highlighting a significant commitment to digital advancement.
Healthcare Industry Performance
The healthcare industry saw the largest sequential growth, up high single digits as compared to the year ago, driven by healthcare provider, pharmaceutical, and biotech clients.
Strong Federal Segment Bookings
In the federal segment, new contract awards totaled $461 million for the third quarter, with a book-to-bill of 1.5 times for the quarter.
Negative Updates
Year-over-Year Revenue Decline
Revenues totaled $1.01 billion, a decrease of 1.9% year over year, with the commercial segment decreasing by 1% and the federal government segment by 3.9%.
Decrease in Assignment Revenues
Assignment revenues totaled $376.4 million, a decrease of 13.2% year over year, reflecting continued softness in portions of the commercial segment sensitive to macroeconomic cycles.
Challenges in Financial Services
Financial services experienced a year-over-year decline, although new wins for the industry outpaced renewals in Q3.
Impact of Government Shutdown
The government shutdown poses a potential headwind, slowing down the cycle of new awards and the ability to ramp up on awards just won.
Company Guidance
During the ASGN Incorporated Third Quarter 2025 Earnings Call, the company provided guidance highlighting strong performance and growth in various sectors. ASGN reported revenues of $1.01 billion with an adjusted EBITDA margin of 11.1%, both at the high end of their guidance ranges. The IT consulting business was a significant growth driver, accounting for 63% of total revenues, with commercial consulting bookings at $324 million and a book-to-bill ratio of 1.2 times. In the federal segment, new contract awards totaled $461 million, with a book-to-bill ratio of 1.5 times for the quarter. The company also emphasized the growing demand for AI and digital transformation, indicating that AI spending is becoming a core aspect of enterprise technology. Despite challenges such as organizational readiness and a shortage of technical talent, ASGN is well-positioned to leverage its capabilities, particularly with the potential positive impact from changes to the H-1B visa process. Looking forward, ASGN projected fourth-quarter revenues between $960 million and $980 million, with an adjusted EBITDA margin of 10.6% to 10.9%.

ASGN Financial Statement Overview

Summary
ASGN's financial statements reflect challenges in revenue growth and profitability, with declining margins and cash flow growth. The balance sheet remains stable with manageable leverage, but the reduced return on equity and cash flow concerns highlight potential risks.
Income Statement
65
Positive
ASGN's income statement shows a declining revenue trend with a negative revenue growth rate of -48.9% TTM, indicating potential challenges in maintaining sales momentum. The gross profit margin remains stable around 28.9%, but the net profit margin has decreased to 3.3% TTM, reflecting reduced profitability. EBIT and EBITDA margins have also declined, suggesting operational inefficiencies. Overall, the income statement reflects moderate financial health with concerns about revenue and profit declines.
Balance Sheet
70
Positive
The balance sheet indicates a moderate debt-to-equity ratio of 0.64 TTM, showing manageable leverage. Return on equity has decreased to 7.2% TTM, which is lower than previous years, indicating reduced efficiency in generating profits from equity. The equity ratio stands at 49.5% TTM, suggesting a stable capital structure. While the balance sheet remains relatively strong, the declining ROE is a concern.
Cash Flow
60
Neutral
ASGN's cash flow statement shows a decline in free cash flow growth by -19.7% TTM, indicating potential cash generation issues. The operating cash flow to net income ratio is not available TTM, but the free cash flow to net income ratio is healthy at 87%. Despite a strong free cash flow to net income ratio, the negative growth in free cash flow raises concerns about future liquidity.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.99B4.10B4.45B4.58B4.01B3.95B
Gross Profit1.15B1.18B1.28B1.37B1.14B1.09B
EBITDA360.70M400.70M464.40M500.90M440.50M370.90M
Net Income130.70M175.20M219.30M268.10M231.80M200.30M
Balance Sheet
Total Assets3.70B3.43B3.54B3.59B3.50B3.28B
Cash, Cash Equivalents and Short-Term Investments83.90M205.20M175.90M70.30M529.60M274.40M
Total Debt1.17B1.10B1.11B1.12B1.10B1.13B
Total Liabilities1.87B1.65B1.65B1.68B1.64B1.69B
Stockholders Equity1.83B1.78B1.89B1.90B1.87B1.59B
Cash Flow
Free Cash Flow283.30M364.70M417.00M270.30M159.00M392.20M
Operating Cash Flow325.80M400.00M456.90M307.80M193.70M424.80M
Investing Cash Flow-348.60M-35.30M-40.50M-510.00M246.50M-219.00M
Financing Cash Flow-17.80M-333.20M-310.90M-256.50M-184.40M-29.00M

ASGN Technical Analysis

Technical Analysis Sentiment
Negative
Last Price43.50
Price Trends
50DMA
48.05
Negative
100DMA
49.52
Negative
200DMA
56.43
Negative
Market Momentum
MACD
-1.20
Positive
RSI
38.97
Neutral
STOCH
17.53
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ASGN, the sentiment is Negative. The current price of 43.5 is below the 20-day moving average (MA) of 45.45, below the 50-day MA of 48.05, and below the 200-day MA of 56.43, indicating a bearish trend. The MACD of -1.20 indicates Positive momentum. The RSI at 38.97 is Neutral, neither overbought nor oversold. The STOCH value of 17.53 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ASGN.

ASGN Risk Analysis

ASGN disclosed 29 risk factors in its most recent earnings report. ASGN reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ASGN Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$2.28B28.7711.46%1.34%9.16%16.38%
75
Outperform
$2.67B24.075.66%8.66%-35.78%
66
Neutral
$1.87B14.737.25%-4.86%-25.15%
62
Neutral
$2.29B6.5012.33%-4.13%2143.48%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
59
Neutral
$1.17B14.8715.40%19.88%51.03%
45
Neutral
$2.14B-40.94%14.34%-13.27%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ASGN
ASGN
43.50
-53.88
-55.33%
FORTY
Formula Systems
148.00
67.84
84.63%
GLOB
Globant SA
63.89
-171.33
-72.84%
DXC
DXC Technology
13.52
-9.31
-40.78%
AI
C3ai
16.08
-11.71
-42.14%
TASK
TaskUs
12.21
-2.48
-16.88%

ASGN Corporate Events

ASGN’s Earnings Call: Mixed Sentiment and Growth Prospects
Oct 24, 2025

The recent earnings call for ASGN Incorporated presented a mixed sentiment, highlighting both strong performances and notable challenges. While the company reported solid outcomes in IT consulting and healthcare sectors, concerns were raised regarding revenue declines and the potential impact of a government shutdown. The outlook remains balanced, with growth prospects tempered by existing challenges.

ASGN Incorporated Reports Strong Q3 2025 Results
Oct 23, 2025

ASGN Incorporated is a prominent provider of IT services and solutions, catering to both commercial and government sectors, with a focus on developing and implementing critical IT and business solutions.

Business Operations and StrategyRegulatory Filings and Compliance
ASGN Updates Bylaws for Enhanced Governance
Neutral
Sep 22, 2025

On September 18, 2025, ASGN Incorporated’s Board of Directors approved amendments to the company’s bylaws. These changes enhance procedural mechanics and disclosure requirements for stockholder nominations and proposals, update provisions for special meetings, clarify resignation procedures, and update indemnification obligations, among other modernizing adjustments.

The most recent analyst rating on (ASGN) stock is a Buy with a $57.00 price target. To see the full list of analyst forecasts on ASGN stock, see the ASGN Stock Forecast page.

Business Operations and StrategyStock BuybackPrivate Placements and Financing
ASGN Secures $100 Million Incremental Term Loan Facility
Positive
Jul 31, 2025

On July 31, 2025, ASGN Incorporated entered into a Second Amendment to its Third Amended and Restated Credit Agreement, introducing an incremental term loan facility of $100 million. This amendment aims to enhance ASGN’s financial flexibility, allowing for strategic allocation of cash flows towards organic business investments, future acquisitions, and share buybacks.

The most recent analyst rating on (ASGN) stock is a Buy with a $100.00 price target. To see the full list of analyst forecasts on ASGN stock, see the ASGN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 26, 2025